132 related articles for article (PubMed ID: 6291801)
21. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
[TBL] [Abstract][Full Text] [Related]
22. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
23. Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure.
Wilson JR; Ferraro N
J Am Coll Cardiol; 1985 Sep; 6(3):556-63. PubMed ID: 2993396
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Massie BM; Packer M; Hanlon JT; Combs DT
J Am Coll Cardiol; 1983 Aug; 2(2):338-44. PubMed ID: 6345633
[TBL] [Abstract][Full Text] [Related]
27. [Hemodynamic effects of oral captopril in patients with critical aortic stenosis].
Martínez Sánchez C; Henne O; Arceo A; Peña M; González H; Chuquiure E; Lupi E
Arch Inst Cardiol Mex; 1996; 66(4):322-30. PubMed ID: 8984953
[TBL] [Abstract][Full Text] [Related]
28. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
[TBL] [Abstract][Full Text] [Related]
29. Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.
Gheorghiade M; Hall V; Lakier JB; Goldstein S
J Am Coll Cardiol; 1989 Jan; 13(1):134-42. PubMed ID: 2562844
[TBL] [Abstract][Full Text] [Related]
30. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
31. Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.
LeJemtel TH; Maskin CS; Mancini D; Sinoway L; Feld H; Chadwick B
Circulation; 1985 Aug; 72(2):364-9. PubMed ID: 3891133
[TBL] [Abstract][Full Text] [Related]
32. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
Halon DA; Rosenfeld T; Hardoff R; Lewis BS
Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685
[TBL] [Abstract][Full Text] [Related]
33. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
[TBL] [Abstract][Full Text] [Related]
34. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.
Creager MA; Massie BM; Faxon DP; Friedman SD; Kramer BL; Weiner DA; Ryan TJ; Topic N; Melidossian CD
J Am Coll Cardiol; 1985 Jul; 6(1):163-73. PubMed ID: 2989349
[TBL] [Abstract][Full Text] [Related]
35. Effects of captopril combined with oxygen therapy at rest and on exercise in patients with chronic bronchitis and pulmonary hypertension.
Pison CM; Wolf JE; Levy PA; Dubois F; Brambilla CG; Paramelle B
Respiration; 1991; 58(1):9-14. PubMed ID: 1649486
[TBL] [Abstract][Full Text] [Related]
36. Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.
Bussmann WD; Störger H; Hadler D; Reifart N; Fassbinder W; Jungmann E; Kaltenbach M
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S50-60. PubMed ID: 2441202
[TBL] [Abstract][Full Text] [Related]
37. [Effects of captopril on hemodynamics, gas exchange and exercise capacity in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease].
Paitl CE; Nery LE; Romaldini H; Herrmann JL; Portugal OP; dos Santos ML; Martinez Filho EE
Arq Bras Cardiol; 1989 Feb; 52(2):59-67. PubMed ID: 2688602
[TBL] [Abstract][Full Text] [Related]
38. Effect of captopril on left ventricular end-systolic pressure-volume and stress-shortening relations in severe cardiac failure.
Lewis BS; Halon DA; Rodeanu ME; Merdler A; Saggie Y; Schneider H; Rosenfeld T; Hardoff R
Clin Cardiol; 1987 Jun; 10(6):340-4. PubMed ID: 3297444
[TBL] [Abstract][Full Text] [Related]
39. [Hemodynamics after sublingual administration of captopril in severe heart failure. A pilot study].
Haude M; Steffen W; Erbel R; Tschollar W; Belz GG; Meyer J
Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1095-100. PubMed ID: 2663409
[TBL] [Abstract][Full Text] [Related]
40. [Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
Volpini M; Gargano M; Cuccia C; Dei Cas L; Gei P; Metra M; Moretti R; Riva S
Cardiologia; 1989 Jun; 34(6):517-23. PubMed ID: 2676168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]